Marie Curie Research Grants Scheme Open to Applications

The Marie Curie Research Grants Scheme funds high quality research that aims to improve the experience for everyone affected by dying, death and bereavement. Applications are invited which address one or more of Marie Curie’s thematic priorities:

• To provide quality care and support for the mental and physical health and wellbeing of people affected by dying, death and bereavement
• To end financial insecurity at the end of life and ensure that everyone has the support they need to address their practical concerns
• To ensure that everyone affected by death and dying – including the family, friends and carers of the dying person- are supported through and beyond the end of life (including bereavement)
• To end inequity in end of life experience by ensuring access to excellent standards of care and support for all

In addition to the above thematic areas, Marie Curie is also inviting proposals in cross-cutting themes and projects aiming to maximise the impact of existing research and evidence. Marie Curie is particularly interested in applications addressing the issue of financial insecurity, as well as applications focusing on real-life impact and translation of research findings into practice or policy.

Applications are invited from lead applicants at recognised Universities, NHS hospitals, hospices or research institutes within the UK. The lead applicant must have a post which covers the entire duration of the proposed study.

It is essential that applicants from hospices form links with an academic institution or NHS partner organisation to build collaborations and obtain support and guidance when preparing their applications, for instance with research governance issues.

Collaborative applications are welcome and named academic/clinical Joint Lead Applicants/Collaborators are permitted – although, if successful, the contracted grant (and associated funding arrangements) will be with the Lead Applicant’s institution in the UK only. In addition, applications involving trials must involve a Clinical Trials Unit (CTU) from the outset.

A total of £750,000 is available for the current funding round. The cost of individual proposals is not expected to exceed £150,000, and smaller proposals in the £30,000 to £150,000 range are welcomed.

Applications must be submitted by 15 November 2021 (17:00 GMT).